• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Virol. TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice

Giuseppe

Emeritus
[Source: Journal of Virology, full page: (LINK). Abstract, edited.]


TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice

Carolin Tarnow 1, G?raldine Engels 2, Annika Arendt 1, Folker Schwalm 1, Hanna Sediri 1, Annette Preuss 2, Peter S. Nelson 3, Wolfgang Garten 1, Hans-Dieter Klenk 1, G?lsah Gabriel 2 and Eva B?ttcher-Friebertsh?user 1#

Author Affiliations: <SUP>1</SUP> Institute of Virology, Philipps-University Marburg, Marburg, Germany <SUP>2</SUP> Heinrich-Pette-Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany <SUP>3</SUP> Fred Hutchinson Cancer Research Center, Seattle, USA

Published ahead of print 12 February 2014, doi: 10.1128/JVI.03799-13 <CITE>JVI.03799-13 </CITE>
<CITE></CITE>
<CITE></CITE>
<CITE></CITE>ABSTRACT

Cleavage of the hemagglutinin (HA) by host proteases is essential for the infectivity of influenza viruses. We have analysed here the role of the serine protease TMPRSS2 activating HA in the human respiratory tract on pathogenesis in a mouse model. Replication of the human H7N9 isolate A/Anhui/1/13 and of human H1N1 and H3N2 viruses was compared in TMPRSS2-knockout (TMPRSS2<SUP>-/-</SUP>) and wildtype (WT) mice. Knockout of TMPRSS2 expression inhibited H7N9 influenza virus replication in explants of murine trachea, bronchi and lung. H1N1 virus replication was also strongly suppressed in airway explants of TMPRSS2<SUP>-/-</SUP> mice, while H3N2 virus replication was only marginally affected. H7N9 and H1N1 viruses were apathogenic in TMPRSS2<SUP>-/-</SUP> mice, whereas WT mice developed severe disease with mortality rates of 100% and 20%, respectively. In contrast, all H3N2 infected TMPRSS2<SUP>-/-</SUP> and WT mice succumbed to lethal infection. Cleavage analysis showed that H7 and H1 are efficiently activated by TMPRSS2, whereas H3 is less susceptible to the protease. Our data demonstrate that TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 and H1N1 influenza virus in mice. In contrast, replication of H3N2 virus appears to depend on another, not yet identified protease, supporting the concept that human influenza viruses differ in protease specificity.


Importance

Cleavage of the hemagglutinin (HA) by host proteases is essential for the infectivity of influenza virus, but little is known about its relevance for pathogenesis in mammals. Here, we show that knockout mice that do not express the HA-activating protease TMPRSS2 are resistant to pulmonary disease with lethal outcome when infected with influenza A viruses of subtypes H7N9 and H1N1, whereas they are not protected from lethal H3N2 virus infection. These findings demonstrate that human influenza viruses differ in protease specificity, and that expression of the appropriate protease in respiratory tissues is essential for pneumotropism and pathogenicity. Our observations also demonstrate that HA-activating proteases and in particular TMPRSS2 are promising targets for influenza therapy.


FOOTNOTES

#Corresponding author: Eva B?ttcher-Friebertsh?user, Institute of Virology, Philipps-University Marburg, Hans-Meerwein-Stra?e 2, 35043 Marburg, Germany, Tel: 0049-6421-2866019, E-mail: friebertshaeuser@staff.uni-marburg.de

Copyright ? 2014, American Society for Microbiology. All Rights Reserved.


-
------
 
Back
Top Bottom